CN106755221A - A kind of preparation method of MFG parent nucleus FR179642 - Google Patents

A kind of preparation method of MFG parent nucleus FR179642 Download PDF

Info

Publication number
CN106755221A
CN106755221A CN201611064451.7A CN201611064451A CN106755221A CN 106755221 A CN106755221 A CN 106755221A CN 201611064451 A CN201611064451 A CN 201611064451A CN 106755221 A CN106755221 A CN 106755221A
Authority
CN
China
Prior art keywords
mfg
fermentation
parent nucleus
preparation
fermentation tank
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201611064451.7A
Other languages
Chinese (zh)
Inventor
游云龙
付静
曹峥
杨亮
赵永俊
蔡云洁
金丹甜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
WUXI FORTUNE PHARMACEUTICAL CO LTD
Original Assignee
WUXI FORTUNE PHARMACEUTICAL CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WUXI FORTUNE PHARMACEUTICAL CO LTD filed Critical WUXI FORTUNE PHARMACEUTICAL CO LTD
Priority to CN201611064451.7A priority Critical patent/CN106755221A/en
Publication of CN106755221A publication Critical patent/CN106755221A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention provides a kind of MFG parent nucleus producing strains, and by adding MFG precursor during the fermentation, the method for obtaining MFG parent nucleus deacylated to MFG precursor belongs to field of biological pharmacy.In the present invention, MFG parent nucleus FR179642 bacterial strains ferment in the medium, MFG precursor FR901379 and the method for passing through multistage temperature control are added at twice during the fermentation, so as to improve the yield of MFG parent nucleus FR179642;The acidified broken wall treatment of zymotic fluid, with Solvent Extract methods, macroporous resin adsorption parses to obtain desorbed solution, then obtains MFG parent nucleus powder by crystallization by desorbed solution.The present invention can be used to synthesize MFG parent nucleus FR179642, and operation sequence is simple, method stabilization, favorable reproducibility.

Description

A kind of preparation method of MFG parent nucleus FR179642
Technical field
The present invention relates to biological pharmacy technical field, more particularly to a kind of preparation side of MFG parent nucleus FR179642 Method.
Background technology
In recent years, with the extensive application of extensive pedigree antibiotic and immunodepressant, chemotherapy of tumors, organ transplant and Chinese mugwort Spreading for disease is grown, the crowd for causing immune system to be suppressed is on the increase, the incidence of disease of deep fungal infection starts to present Obvious ascendant trend, and with the utilization of antifungal drug, the drug resistance of fungi is also more and more stronger so that antifungal drug Using there is swift and violent increased trend.Therefore, the medicine of anti-deep fungal infection has turned into one of study hotspot of anti-infectious agent, day Benefit causes the concern of people.
Echinocandin is the new antifungal of a class, and the mechanism of action with current clinical conventional antifungal drug is obvious not Together, it is β -1, the inhibitor of 3- glucan synthases acts on the cell membrane of fungi.Cell membrane is fungi and mammalian cell Between maximum difference, so the synthesis of interference cell wall, influence the integrality of cell membrane that fungal cell will be caused dead and right People's fanout free region, therefore side effect is smaller, security is higher.
MFG is a kind of water-soluble semi synthesis echinocandin antifungal agent thing, and FR179642 is synthesis meter Ka Fen Net parent nucleus, CAS accession number:168110-44-9, chemical formula:C35H52N8O20S, molecular weight:936.90.The chemistry knot of FR179642 Structure formula is as follows:
At present, the report in terms of relevant FR179642 synthesis or preparation is detected in publication number KR20140039753's (A) In South Korea's patent of invention.It passes through intermediate FR901379 through deacetylation, and is prepared by starting material of FR901379 FR179642.Specific syntheti c route is as follows:
But, there is preparation cost defect high in above-mentioned prior art.Meanwhile, there is no in the prior art for FR179642 Relevant report prepared by fermentation, belongs to the blanking technique of current industry.
The content of the invention
It is an object of the invention to disclose a kind of preparation method of MFG parent nucleus FR179642,
For achieving the above object, the invention provides the preparation method of MFG parent nucleus FR179642, including with Lower step:
Step (1), a small amount of MFG parent nucleus FR179642 producing strains spore suspensions are taken, are inoculated on seed culture medium, In at 24~28 DEG C, 40~50h is cultivated;
Step (2), seed culture medium is inoculated in fermentation tank and fermentation medium is added, reached when the bacterium in fermentation tank is dense MFG precursor FR901379 is added after to stable state, MFG precursor is added after continuing 40~60h of fermentation Dual-stage temperature control, fermentation completion are used in FR901379, the step (2) to be carried out putting tank extracting zymotic fluid;
Step (3), make the pH of zymotic fluid in 3~4 to adding acid in zymotic fluid, then plate-frame filtering adds polar solvent Concentration is stripped, concentrate is obtained;
Step (4), by concentrate through macroporous resin adsorption, parsed using polar solvent, obtain MFG parent nucleus FR179642 desorbed solutions;
Step (5), MFG parent nucleus FR179642 desorbed solutions is crystallized, drying, obtain in powdered MFG Parent nucleus FR179642.
As a further improvement on the present invention, the component of the seed culture medium in the step (1) is:Glucose 20~ 35g/L, 5~15g/L of dusty yeast, 5~15g/L of soybean cake powder, 0.5~1.5g/L of dipotassium hydrogen phosphate, 0.1~1.0g/ of sodium chloride L, 0.1~1.0g/L of magnesium sulfate, 0.1~0.5g/L of calcium carbonate, balance of water.
As a further improvement on the present invention, the component of the fermentation medium in the step (2) is:Glucose 5~ 15g/L, 70~90g/L of dusty yeast, 6~10g/L of soybean cake powder, 1~5g/L of dipotassium hydrogen phosphate, 1~5g/L of sodium chloride, magnesium sulfate 0.2~0.4g/L, 0.1~0.5g/L of calcium carbonate, balance of water.
As a further improvement on the present invention, in the step (2), MFG precursor FR901379's in fermentation tank Concentration stabilization is between 500~2000 μ g/mL.
As a further improvement on the present invention, in the step (2), in the step (2), from original state to fermentation tank In the dense fermentation stage for reaching stable state of interior bacterium, the temperature control in fermentation tank is at 30~34 DEG C;Bacterium in fermentation tank is dense Stable state is reached into putting the tank stage, and the temperature control in fermentation tank is at 26~30 DEG C.
As a further improvement on the present invention, the acid in the step (3) is selected from the dilute sulfuric acid that concentration is 5~10wt%, 5 The dilute sulfuric acid of~10wt% or the phosphoric acid,diluted of 5~10wt%.
As a further improvement on the present invention, the polar solvent in the step (4) is selected from the alcohol of C1~C4;The step (4) macroreticular resin in is selected from HP20 macroreticular resins, D1300 macroreticular resins or SP207 macroreticular resins.
As a further improvement on the present invention, the crystallization mode in the step (5) is that solvent settles crystallization or concentrates Crystallization.
As a further improvement on the present invention, the used solvent of the solvent sedimentation crystallization is selected from petroleum ether, n-hexane Or hexamethylene.
As a further improvement on the present invention, the drying mode in the step (5) is vacuum drying, vacuum drying dry Dry temperature is 40~50 DEG C, and vacuum is 0.1~0.5MPa.
Compared with prior art, the beneficial effects of the invention are as follows:In the present invention, MFG parent nucleus FR179642 bacterial strains Ferment in the medium, add MFG precursor FR901379 and the side for passing through multistage temperature control at twice during the fermentation Method, improves the yield of MFG parent nucleus FR179642;The acidified broken wall treatment of zymotic fluid, with Solvent Extract methods, macropore Resin adsorption parses to obtain desorbed solution, then obtains MFG parent nucleus powder by crystallization by desorbed solution.The present invention can be used for Synthesis MFG parent nucleus FR179642, and operation sequence is simple, method stabilization, favorable reproducibility.
Specific embodiment
With reference to each implementation method, the present invention is described in detail, but it should explanation, these implementation methods are simultaneously Non- limitation of the present invention, those of ordinary skill in the art are according in these implementation method institutes works energy, method or structure Equivalent transformation or replacement, belong within protection scope of the present invention.
Unless there is specified otherwise in specification, component, the raw material in each embodiment in the present invention are pure using analysis Rank.In addition, " g " in each embodiment is unit of weight " gram ";" h " is chronomere's " hour ";" ml " is volume unit " milli Rise ";" room temperature " is 23 DEG C;“BV/H”:The expression of space flow speed, that is, refer to the unit interval (hour) to flow through unit volume tree in post The average liquid measure of fat.“HPLC”:High performance liquid chromatography.
Embodiment one:
The preparation method of MFG parent nucleus FR179642, comprises the following steps.
Step (1), a small amount of MFG parent nucleus FR179642 producing strains spore suspensions are taken, are inoculated on seed culture medium, In at 24 DEG C, 50h is cultivated.Component in the seed culture medium is (unit:g/L):Glucose 20, dusty yeast 5, soybean cake powder 5, Dipotassium hydrogen phosphate 0.5, sodium chloride 0.1, magnesium sulfate 0.1, calcium carbonate 0.1, balance of water.
Step (2), seed culture medium is inoculated in fermentation tank and fermentation medium is added, in culture 60 at 24~28 DEG C~ 70h.MFG precursor FR901379 is added after the bacterium in fermentation tank is dense reaches stable state, after continuing fermentation 40h, is added MFG precursor FR901379.In the two fermentation stages, from original state to fermentation tank in bacterium it is dense reach stabilization shape First fermentation stage of state, the temperature control in fermentation tank is at 30 DEG C.Bacterium from fermentation tank is dense to reach stable state to putting In second fermentation stage of tank, the temperature control in fermentation tank is at 26 DEG C.Component in the fermentation medium is (unit:g/ L):Glucose 5, dusty yeast 70, soybean cake powder 6, dipotassium hydrogen phosphate 1, sodium chloride 1, magnesium sulfate 0.2, calcium carbonate 0.1 is balance of Water.In the present embodiment, in second fermentation stage, the concentration stabilization of the MFG precursor FR901379 in fermentation tank exists 500 μ g/mL or so.
Step (3), fermentation completion extracted after putting tank.When extracting zymotic fluid, it is to addition concentration in fermentation tank first The dilute sulfuric acid of 5wt%, so that the system of zymotic fluid is acidified to pH in 3 in fermentation tank, after crossing sheet frame, plus methyl alcohol is used as polar solvent Extracting concentration, obtains MFG parent nucleus FR179642 concentrates.
Step (4), MFG parent nucleus FR179642 concentrates are entered using the macroporous resin adsorption post for being filled with HP20 Row absorption.Adsorption flow rate controls 0.5~1.5BV/H, is washed after the completion of absorption, is 60wt% methyl alcohol as polar solvent with concentration Parsed, parsed 1~2BV/H of flow velocity, merged active principle, obtained MFG parent nucleus FR179642 desorbed solutions.
Step (5), the crystallization of MFG parent nucleus FR179642 desorbed solutions, dry, and obtain in the MFG parent nucleus of powdery FR179642.In the present embodiment, crystallization mode is condensing crystallizing, and crystallization temperature is 40 DEG C.Drying mode is vacuum drying, is dried 40 DEG C of temperature, vacuum drying vacuum is 0.1MPa.
MFG parent nucleus FR179642 obtained by the present embodiment normalizes purity 85.5% through HPLC detections.
Embodiment two:
The preparation method of MFG parent nucleus FR179642, comprises the following steps.
Step (1), a small amount of MFG parent nucleus FR179642 producing strains spore suspensions are taken, are inoculated on seed culture medium, In at 28 DEG C, 40h is cultivated.Component in the seed culture medium is (unit:g/L):Glucose 35, dusty yeast 15, soybean cake powder 15, dipotassium hydrogen phosphate 1.5, sodium chloride 1.0, magnesium sulfate 1.0, calcium carbonate 0.5, balance of water.
Step (2), seed culture medium is inoculated in fermentation tank and fermentation medium is added, in culture 60 at 24~28 DEG C~ 70h。
MFG precursor FR901379 is added after the bacterium in fermentation tank is dense reaches stable state, after continuing fermentation 60h, Add MFG precursor FR901379.In the two fermentation stages, from original state to fermentation tank in bacterium it is dense reach it is steady Determine first fermentation stage of state, the temperature control in fermentation tank is at 31 DEG C.Stable state is reached from the bacterium of fermentation tank is dense extremely Put in second fermentation stage of tank, the temperature control in fermentation tank is at 27 DEG C.Component in the fermentation medium component is (single Position:g/L):Glucose 15, dusty yeast 90, soybean cake powder 10, dipotassium hydrogen phosphate 5, sodium chloride 5, magnesium sulfate 0.4, calcium carbonate 0.5, Balance of water.In the present embodiment, in second fermentation stage, the MFG precursor concentration stabilization in fermentation tank is 2000 μ g/mL or so.
Step (3), fermentation completion extracted after putting tank.When extracting zymotic fluid, it is to addition concentration in fermentation tank first The watery hydrochloric acid of 5wt%, so that the system of zymotic fluid is acidified to pH in 3 in fermentation tank, after crossing sheet frame, plus ethanol is used as polar solvent Concentration is stripped, MFG parent nucleus FR179642 concentrates are obtained.
Step (4), concentrate is adsorbed using the macroporous resin adsorption post for being filled with SP207.Adsorption flow rate is controlled 0.5~1.5BV/H, washes after the completion of absorption, is parsed as polar solvent with the ethanol that concentration is 60wt%, parses flow velocity 1~2BV/H, merges active principle, obtains MFG parent nucleus FR179642 desorbed solutions.
Step (5), by the crystallization of MFG parent nucleus FR179642 desorbed solutions, dry, obtain female in the MFG of powdery Core FR179642.Crystallization mode is 50 DEG C of condensing crystallizings.Drying mode is vacuum drying, 50 DEG C of drying temperature, vacuum is 0.5MPa。
MFG parent nucleus FR179642 obtained by the present embodiment normalizes purity 85.7% through HPLC detections.
Embodiment three:
The preparation method of MFG parent nucleus FR179642, comprises the following steps.
Step (1), a small amount of MFG parent nucleus FR179642 producing strains spore suspensions are taken, be inoculated on culture medium, in At 26 DEG C, 48h is cultivated.Component in the seed culture medium is (unit:g/L):Glucose 25, dusty yeast 10, soybean cake powder 10, Dipotassium hydrogen phosphate 1, sodium chloride 0.5, magnesium sulfate 0.5, calcium carbonate 0.2, balance of water.
Step (2), seed culture medium is inoculated in fermentation tank and fermentation medium is added, in culture 60 at 24~28 DEG C~ 70h。
MFG precursor FR901379 is added after the bacterium in fermentation tank is dense reaches stable state.After continuing fermentation 50h, Add MFG precursor FR901379.In the two fermentation stages, from original state to fermentation tank in bacterium it is dense reach it is steady Determine first fermentation stage of state, the temperature control in fermentation tank is at 33 DEG C.Bacterium from fermentation tank is dense to reach stable state Into putting second fermentation stage of tank, the temperature control in fermentation tank is at 28 DEG C.Component in the fermentation medium is (single Position:g/L):Glucose 10, dusty yeast 80, soybean cake powder 8, dipotassium hydrogen phosphate 2, sodium chloride 2, magnesium sulfate 0.3, calcium carbonate 0.3, Balance of water.In the present embodiment, in second fermentation stage, the stabilization of the MFG precursor FR901379 in fermentation tank In 700 μ g/mL.
Carry out putting tank extraction after the completion of step (3), fermentation.When extracting zymotic fluid, it is to addition concentration in fermentation tank first The watery hydrochloric acid of 5wt%, so that the system of zymotic fluid is acidified to pH in 3.5 in fermentation tank, plate-frame filtering, then to adding in fermentation tank Plus the methyl alcohol that concentration is 60wt% is stripped concentration as polar solvent, obtains MFG parent nucleus FR179642 desorbed solutions.
Step (4), MFG parent nucleus FR179642 desorbed solutions are carried out using D1300 macroporous resin adsorptions post is filled with Absorption, is parsed with the methyl alcohol that concentration is 60wt% as polar solvent, parses 1~2BV/H of flow velocity, merges active principle, It is concentrated to give MFG parent nucleus FR179642 desorbed solutions.
Step (5), by the crystallization of MFG parent nucleus FR179642 desorbed solutions, filtering is dried, obtained in powdered rice card Fragrant net parent nucleus FR179642.Crystallization mode is that solvent settles crystallization, and is specially:To MFG parent nucleus FR179642 desorbed solutions 15~20 times of hexamethylenes of volume of middle addition.In the present embodiment, drying mode is vacuum drying, 40 DEG C of drying temperature, vacuum It is 0.2MPa to spend.
MFG parent nucleus FR179642 obtained by the present embodiment normalizes purity 86.1% through HPLC detections.
Example IV:
The preparation method of MFG parent nucleus FR179642, comprises the following steps.
Step (1), a small amount of FR179642 producing strains spore suspensions are taken, be inoculated on culture medium, at 26 DEG C, culture 44h.Component in the seed culture medium is (unit:g/L):Glucose 20, dusty yeast 15, soybean cake powder 5, dipotassium hydrogen phosphate 0.5, sodium chloride 0.1, magnesium sulfate 0.1, calcium carbonate 0.1, balance of water.
Step (2), seed culture medium is inoculated in fermentation tank and fermentation medium is added, in cultivating 60 at 24~28 DEG C ~70h.
MFG precursor FR901379 is added after the bacterium in fermentation tank is dense reaches stable state, after continuing fermentation 55h, Add MFG precursor FR901379.In the two fermentation stages, from original state to fermentation tank in bacterium it is dense reach it is steady Determine a fermentation stage of state, the temperature control in fermentation tank is at 32 DEG C.Bacterium from fermentation tank is dense to reach stable state extremely Put in second fermentation stage of tank, the stability contorting in fermentation tank is at 29 DEG C.Component in the fermentation medium component is (single Position:g/L):Glucose 5, dusty yeast 70, soybean cake powder 6, dipotassium hydrogen phosphate 1, sodium chloride 1, magnesium sulfate 0.2, calcium carbonate 0.1 is remaining It is water to measure.In this example, in second fermentation stage, the concentration stabilization of the MFG precursor FR901379 in fermentation tank In 800 μ g/mL or so.
Step (3), fermentation completion extracted after putting tank.When extracting zymotic fluid, it is to addition concentration in fermentation tank first The phosphoric acid,diluted of 5wt%, so that the system of zymotic fluid is acidified to pH in 3 in fermentation tank, after crossing sheet frame, plus ethanol is used as polar solvent Extracting concentration, obtains MFG parent nucleus FR179642 concentrates.
Step (4), MFG parent nucleus FR179642 concentrates are entered using the macroporous resin adsorption post for being filled with D1300 Row absorption.Adsorption flow rate controls 0.5~1.5BV/H, is washed after the completion of absorption, molten as polarity with the ethanol that concentration is 60wt% Agent is parsed, and parses 1~2BV/H of flow velocity, merges active principle, obtains MFG parent nucleus FR179642 desorbed solutions.
Step (5), by the crystallization of MFG parent nucleus FR179642 desorbed solutions, dry, obtain in powdered MFG Parent nucleus FR179642.Crystallization mode is that solvent settles crystallization, and is specially:Add in MFG parent nucleus FR179642 desorbed solutions Enter 15~20 times of n-hexanes of volume.Crystallization and filtration is simultaneously dried.Specifically, drying mode is vacuum drying, drying temperature 40 DEG C, vacuum is 0.3MPa.
MFG parent nucleus FR179642 obtained by the present embodiment normalizes purity 85.7% through HPLC detections.
Embodiment five:
The preparation method of MFG parent nucleus FR179642, comprises the following steps.
Step (1), a small amount of FR179642 producing strains spore suspensions are taken, be inoculated on culture medium, at 26 DEG C, culture 40h.Component in the seed culture medium is (unit:g/L):Glucose 35, dusty yeast 15, soybean cake powder 15, dipotassium hydrogen phosphate 1.5, sodium chloride 1.0, magnesium sulfate 1.0, calcium carbonate 0.5, balance of water.
Step (2), seed culture medium is inoculated in fermentation tank and fermentation medium is added, in cultivating 60 at 24~28 DEG C ~70h.
MFG precursor FR901379 is added after the bacterium in fermentation tank is dense reaches stable state, after continuing fermentation 60h, Add MFG precursor FR901379.In the two fermentation stages, from original state to fermentation tank in bacterium it is dense reach it is steady Determine a fermentation stage of state, the temperature control in fermentation tank is at 34 DEG C.Bacterium from fermentation tank is dense to reach stable state extremely Put in second fermentation stage of tank, the stability contorting in fermentation tank is at 30 DEG C.Component in the fermentation medium component is (single Position:g/L):Glucose 15, dusty yeast 90, soybean cake powder 10, dipotassium hydrogen phosphate 5, sodium chloride 5, magnesium sulfate 0.4, calcium carbonate 0.5, Balance of water.In this example, in second fermentation stage, the concentration of the MFG precursor FR901379 in fermentation tank is steady It is scheduled on 2000 μ g/mL or so.
Step (3), fermentation completion extracted after putting tank;When extracting zymotic fluid, it is to addition concentration in fermentation tank first The watery hydrochloric acid of 5wt%, so that the system of zymotic fluid is acidified to pH in 3 in fermentation tank, after crossing sheet frame, plus methyl alcohol is used as polar solvent Extracting concentration, obtains MFG parent nucleus FR179642 concentrates.
Step (4), the MFG parent nucleus FR179642 concentrates for obtaining use the macroporous resin adsorption for being filled with D1300 Post is adsorbed.Adsorption flow rate controls 0.5~1.5BV/H, is washed after the completion of absorption, is solved with the methyl alcohol that concentration is 60wt% Analysis, parses 1~2BV/H of flow velocity, merges active principle, obtains MFG parent nucleus FR179642 desorbed solutions.
Step (5), by the crystallization of MFG parent nucleus FR179642 desorbed solutions, dry, obtain in powdered MFG Parent nucleus FR179642.Crystallization mode is that solvent settles crystallization, and is specially:Add in MFG parent nucleus FR179642 desorbed solutions Enter 15~20 times of petroleum ethers of volume.Crystallization and filtration is simultaneously dried.Specifically, drying mode is vacuum drying, drying temperature 40 DEG C, vacuum is 0.4MPa.
MFG parent nucleus FR179642 obtained by the present embodiment normalizes purity 86.3% through HPLC detections.
Those listed above is a series of to be described in detail only for feasibility implementation method of the invention specifically Bright, they simultaneously are not used to limit the scope of the invention, all equivalent implementations made without departing from skill spirit of the present invention Or change should be included within the scope of the present invention.
It is obvious to a person skilled in the art that the invention is not restricted to the details of above-mentioned one exemplary embodiment, Er Qie In the case of without departing substantially from spirit or essential attributes of the invention, the present invention can be in other specific forms realized.Therefore, no matter From the point of view of which point, embodiment all should be regarded as exemplary, and be nonrestrictive, the scope of the present invention is by appended power Profit requires to be limited rather than described above, it is intended that all in the implication and scope of the equivalency of claim by falling Change is included in the present invention.
Moreover, it will be appreciated that although the present specification is described in terms of embodiments, not each implementation method is only wrapped Containing an independent technical scheme, this narrating mode of specification is only that for clarity, those skilled in the art should Specification an as entirety, the technical scheme in each embodiment can also be formed into those skilled in the art through appropriately combined May be appreciated other embodiment.

Claims (10)

1. the preparation method of MFG parent nucleus FR179642, it is characterised in that comprise the following steps:
Step (1), a small amount of MFG parent nucleus FR179642 producing strains spore suspensions are taken, be inoculated on seed culture medium, in 24 At~28 DEG C, 40~50h is cultivated;
Step (2), seed culture medium is inoculated in fermentation tank and fermentation medium is added, when the bacterium in fermentation tank is dense reach it is steady MFG precursor FR901379 is added after determining state, MFG precursor FR901379, institute are added after continuing 40~60h of fermentation State step (2) middle using dual-stage temperature control, fermentation completion carries out putting tank extracting zymotic fluid;
Step (3), make the pH of zymotic fluid in 3~4 to adding acid in zymotic fluid, plate-frame filtering, then adding polar solvent is carried out Extracting concentration, obtains concentrate;
Step (4), by concentrate through macroporous resin adsorption, parsed using polar solvent, obtain MFG parent nucleus FR179642 Desorbed solution;
Step (5), MFG parent nucleus FR179642 desorbed solutions is crystallized, drying, obtain in powdered MFG parent nucleus FR179642。
2. preparation method according to claim 1, it is characterised in that the component of the seed culture medium in the step (1) For:20~35g/L of glucose, 5~15g/L of dusty yeast, 5~15g/L of soybean cake powder, 0.5~1.5g/L of dipotassium hydrogen phosphate, chlorination 0.1~1.0g/L of sodium, 0.1~1.0g/L of magnesium sulfate, 0.1~0.5g/L of calcium carbonate, balance of water.
3. preparation method according to claim 1, it is characterised in that the component of the fermentation medium in the step (2) For:5~15g/L of glucose, 70~90g/L of dusty yeast, 6~10g/L of soybean cake powder, 1~5g/L of dipotassium hydrogen phosphate, sodium chloride 1 ~5g/L, 0.2~0.4g/L of magnesium sulfate, 0.1~0.5g/L of calcium carbonate, balance of water.
4. preparation method according to claim 1, it is characterised in that in the step (2), the MFG in fermentation tank The concentration stabilization of precursor FR901379 is between 500~2000 μ g/mL.
5. preparation method according to claim 1, it is characterised in that in the step (2), from original state to fermentation tank In the dense fermentation stage for reaching stable state of interior bacterium, the temperature control in fermentation tank is at 30~34 DEG C;Bacterium in fermentation tank is dense Stable state is reached into putting the tank stage, and the temperature control in fermentation tank is at 26~30 DEG C.
6. preparation method according to claim 1, it is characterised in that the acid in the step (3) be selected from concentration be 5~ The phosphoric acid,diluted of the dilute sulfuric acid of 10wt%, the dilute sulfuric acid of 5~10wt% or 5~10wt%.
7. preparation method according to claim 1, it is characterised in that the polar solvent in the step (4) be selected from C1~ The alcohol of C4;Macroreticular resin in the step (4) is selected from HP20 macroreticular resins, D1300 macroreticular resins or SP207 macropore trees Fat.
8. preparation method according to claim 1, it is characterised in that crystallization mode in the step (5) is heavy for solvent Drop crystallization or condensing crystallizing.
9. preparation method according to claim 8, it is characterised in that the used solvent of the solvent sedimentation crystallization is selected from Petroleum ether, n-hexane or hexamethylene.
10. preparation method according to claim 1, it is characterised in that drying mode in the step (5) is dry for vacuum Dry, vacuum drying drying temperature is 40~50 DEG C, and vacuum is 0.1~0.5MPa.
CN201611064451.7A 2016-11-28 2016-11-28 A kind of preparation method of MFG parent nucleus FR179642 Pending CN106755221A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611064451.7A CN106755221A (en) 2016-11-28 2016-11-28 A kind of preparation method of MFG parent nucleus FR179642

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611064451.7A CN106755221A (en) 2016-11-28 2016-11-28 A kind of preparation method of MFG parent nucleus FR179642

Publications (1)

Publication Number Publication Date
CN106755221A true CN106755221A (en) 2017-05-31

Family

ID=58904387

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611064451.7A Pending CN106755221A (en) 2016-11-28 2016-11-28 A kind of preparation method of MFG parent nucleus FR179642

Country Status (1)

Country Link
CN (1) CN106755221A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111434675A (en) * 2019-01-11 2020-07-21 苏州纳微科技股份有限公司 Separation and purification method of micafungin mother ring
CN114874919A (en) * 2022-05-09 2022-08-09 中国科学院青岛生物能源与过程研究所 Micafungin precursor FR901379 high-yield strain and application thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1218507A (en) * 1996-03-08 1999-06-02 藤泽药品工业株式会社 Deacylation of cyclic lipopetides
CN102432674A (en) * 2010-09-29 2012-05-02 上海天伟生物制药有限公司 Method for purifying cyclic lipopeptide compound or salt thereof
WO2012103800A1 (en) * 2011-01-31 2012-08-09 上海天伟生物制药有限公司 Method for preparing cyclic lipopeptide compound
CN102952178A (en) * 2011-08-24 2013-03-06 华北制药集团新药研究开发有限责任公司 Preparation method for high-purity echinocandin compound
CN103304640A (en) * 2012-03-14 2013-09-18 浙江医药股份有限公司新昌制药厂 Method for extracting echinocandins compound from fermentation liquid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1218507A (en) * 1996-03-08 1999-06-02 藤泽药品工业株式会社 Deacylation of cyclic lipopetides
CN102432674A (en) * 2010-09-29 2012-05-02 上海天伟生物制药有限公司 Method for purifying cyclic lipopeptide compound or salt thereof
WO2012103800A1 (en) * 2011-01-31 2012-08-09 上海天伟生物制药有限公司 Method for preparing cyclic lipopeptide compound
CN102952178A (en) * 2011-08-24 2013-03-06 华北制药集团新药研究开发有限责任公司 Preparation method for high-purity echinocandin compound
CN103304640A (en) * 2012-03-14 2013-09-18 浙江医药股份有限公司新昌制药厂 Method for extracting echinocandins compound from fermentation liquid

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
SATOSHI UEDA等: "Screening and characterization of microorganisms", 《THE JOURNAL OF ANTIBIOTICS》 *
夏焕章等: "最适发酵温度的选择与控制", 《发酵工艺学》 *
滕云: "棘白菌素类抗真菌药物的结构与微生物合成", 《中国医药工业杂志》 *
赵国玲等: "棘白霉素脱酰酶基因工程菌的构建及应用研究", 《中国生物工程杂质》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111434675A (en) * 2019-01-11 2020-07-21 苏州纳微科技股份有限公司 Separation and purification method of micafungin mother ring
CN114874919A (en) * 2022-05-09 2022-08-09 中国科学院青岛生物能源与过程研究所 Micafungin precursor FR901379 high-yield strain and application thereof

Similar Documents

Publication Publication Date Title
CN106399431A (en) Preparation method of micafungin precursor
CN101702984B (en) Phellinus igniarius mycelium liquid fermentation method by utilizing fungal elicitor for improving yield of flavone of phellinus igniarius
CN102965418A (en) Extraction method for biological oat polypeptide and applications thereof
CN101935358A (en) Ganoderma lucidum polysaccharide and preparation method thereof
CN104277982B (en) Tricyclic sesquiterpenoid compound as well as preparation method and applications thereof
CN106692211B (en) Preparation method of antrodia camphorata mycelium triterpenes extract
CN103360351A (en) Isopimarane diterpenoid compounds and application thereof
CN106755221A (en) A kind of preparation method of MFG parent nucleus FR179642
CN106167779A (en) A kind of bacillus amyloliquefaciens and the method preparing succinyl ononin in nonaqueous phase
CN105368895A (en) Method for preparing dinghu scale toadstool intracellular and extracellular polysaccharide with antioxidant activity
CN104031109B (en) A kind of method of fermentable purifying tea saponin
CN100494189C (en) Benzofurantone compound, its production and use
CN104894173B (en) A kind of preparation method of curcumin derivate
CN103772460B (en) The extraction process of cordycepin in silkworm Chinese caterpillar fungus
CN104871973A (en) Method for accelerating accumulation of saponin in ginseng adventitious roots by adopting two types of inductors
CN104450665B (en) A kind of fixed phaffiafhodozyma and method and the application for preparing new Cohan sugar
CN104774794A (en) Strain capable of producing D-mannose isomerase and method for producing D-mannose isomerase by using same
CN103130875B (en) Method for extracting polymyxin B from fermentation broth
CN103571806A (en) Method for rapidly separating and purifying dextran sucrase through two aqueous phase extraction
CN104726342B (en) Safflower endogenetic fungus, Thick many candies and its production and use
CN103031264A (en) Salinomycin high-yield strain
CN113274944A (en) Decolorizing system is drawed to saponin
CN108251490B (en) Fermentation medium and fermentation method for improving ganoderic acid A in liquid fermentation ganoderma lucidum mycelia
CN105614841B (en) A kind of Cordyceps militaris method for preparing extractive rich in bioactive substance
CN105695544A (en) Method for extracting cyclo(Pro-Gly)dipeptide from Bacillus coagulans

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20170531

RJ01 Rejection of invention patent application after publication